Description
Global Dry Age-Related Macular Degeneration Market Analysis and Forecast Report 2030
Market Overview
CRI has released a report titled Dry Age-Related Macular Degeneration Market – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031. The market is anticipated to reach USD 15,351.07 million by 2030 at a CAGR of 8.20% during the forecast period.
. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Dry Age-Related Macular Degeneration Market Market: Key Players
Santen Pharmaceuticals Inc. (Japan)
Allergan plc (Ireland)
Bausch Health (Canada)
Alimera Science Inc. (US)
Phio Pharmaceuticals Corp (US)
Ocumension Therapeutics Co. Ltd (China)
Belite Bio Inc. (US)
Kubota Vision Inc. (US)
Iveric Bio (US)
Eyestem Research Pvt Ltd (India)
Yuyang DNU Co., Ltd (South Korea)
Stealth Biotherapeutics Inc. (US)
Segmentation
Scope of the Report & Segmentation
Global Dry Age-Related Macular DegenerationMarket, by Stages
Early AMD
Intermediate AMD
Late AMD
Global Dry Age-Related Macular Degeneration Market, by Age Group
Above 40 Years
Above 60 Years
Above 75 Years
Global Dry Age-Related Macular Degeneration Market, by Diagnosis & Treatment
Treatment
Nutrition Therapy
Antioxidants
Vitamins
Zinc
Copper
Omega-3 fatty acids
Others
Others
Telescopic Lens Implant
Diagnosis
Fluorescein Angiogram
Preliminary Test
Optical Coherence Tomography
Others
Global Dry Age-Related Macular Degeneration Market, by Route of Administration
Oral
Injectables
Global Dry Age-Related Macular Degeneration Market, by End User
Hospitals & Clinics
Diagnostic Centers
Academic Research Institutes
Others
Global Dry Age-Related Macular Degeneration Market, by Region
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
Dry Age-Related Macular Degeneration Market Market Dynamics
Dry Age-Related Macular Degeneration Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Dry Age-Related Macular Degeneration Market Market growth?
Which segment accounted for the largest Dry Age-Related Macular Degeneration Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in CRI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Related Reports: Cancer Microbiome Sequencing Market – A Global and Regional Analysis: Focus on Offering, Application, Technology, End User, and Region – Analysis and Forecast, 2021-2031
Table of Contents
Contents
1. Executive Summary
2. Dry Age-Related Macular Degeneration Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Dry Age-Related Macular Degeneration Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Dry Age-Related Macular Degeneration Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Dry Age-Related Macular Degeneration Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Santen Pharmaceuticals Inc. (Japan)
Allergan plc (Ireland)
Bausch Health (Canada)
Alimera Science Inc. (US)
Phio Pharmaceuticals Corp (US)
Ocumension Therapeutics Co. Ltd (China)
Belite Bio Inc. (US)
Kubota Vision Inc. (US)
Iveric Bio (US)
Eyestem Research Pvt Ltd (India)
Yuyang DNU Co., Ltd (South Korea)
Stealth Biotherapeutics Inc. (US)
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Reviews
There are no reviews yet.